Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00536341 · COMPLETED
Trial details
- NCT number
- NCT00536341
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.